Sevinç Yenice Aktaş, Derya Hırçın Cenger

Bir Eğitim ve Araştırma Hastanesindeki Transfüzyon Merkezi Verilerinin Değerlendirilmesi

Amaç: Kan transfüzyonu birçok risk içermekle birlikte hayat kurtaran bir doku/organ transplantasyonudur. Kıymetli ve pahalı bir tedavi şekli olan transfüzyon kararı titizlikle alınmalı, hastaların ve ürünlerin takibi çok dikkatli şekilde yapılmalıdır. Bu çalışmanın amacı hastanemizin 2016-2020 yılları arasında kullanılan kan ve kan ürünü verilerinin retrospektif olarak incelenmesidir. Gereç ve Yöntem: Hastanemizin 2016-2020 yılları arasında transfüzyon merkezi verileri retrospektif olarak incelendi. Bulgular: Kan bileşeni transfüzyonu planlanan %74,7’si erkek, %25,3’ü kadın toplam 7282 hasta çalışmaya dahil edildi. Hastaların ortalama yaşı 60,94±1,4 yıl idi. En sık görülen kan grupları A Rh+ ve O Rh+ olarak belirlendi. Eritrosit süspansiyonu (%65,9), taze donmuş plazma (%22,4), aferez trombosit süspansiyonu (%5,8) en sık kullanılan kan bileşenleri olarak bulundu. Otuz bin dört yüz otuz beş ünite kan bileşeninin transfüzyon merkezine tedarik maliyeti 5.563.335 TL, 643 ünite kan ürününün imhası ile ilgili maliyet ise 29.728 TL olarak belirlendi. İmha oranı %2,11 olarak belirlendi. Sonuç: Kan ve kan ürünleri çok değerli kaynaklar olduğundan, hastane verileri analiz edilerek ihtiyaç planları yapılmalı ve imhalar azaltılmalıdır.

Evaluation of Transfusion Center Data in a Training and Research Hospital

Objectives: Although blood transfusion involves many risks, it is a life-saving tissue/organ transplantation. The decision of transfusion, which is a valuable and expensive form of treatment, should be taken meticulously, and patients and products should be followed very carefully. The aim of this study is to retrospectively analyze the blood and blood product data used in our hospital between 2016 and 2020. Materials and Methods: Transfusion center data between 2016 and 2020 at our hospital were analyzed retrospectively. Results: Seven thousand two hundred and eighty-two patients, of whom 74.7% were male and 25.3% were female, who were planned for blood component transfusion were included. The mean age of the patients was 60.94±1.4 years. The most common blood groups were determined as A Rh+ and O Rh+. Erythrocyte suspension (65.9%), fresh frozen plasma (22.4%), apheresis platelet suspension (5.8%) were found to be the most commonly used blood components. The cost of supplying 30,435 units of blood components to the transfusion center was determined as 5,563,335 TL while the cost associated with the discard of 643 units of blood products was determined as 29,728 TL. The discard rate was determined as 2.11%. Conclusion: After transfusion, reactions and undesirable effects can be seen, and the use of blood products is an application that should be evaluated in detail in terms of cost. In this context, more detailed cost-effectiveness studies are needed.

PDF

___

1. İşler Y, Kaya H, İşler Ş, et al. “ Characteristics of Blood Transfusion Patients in the Emergency Department”. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2019;45: 275-280.
2. Shander A, Hofmann A, Gombotz H, et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol. 2007;21:271-289.
3. Toner RW, Pizzi L, Leas B, et al. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy. 2011;9:29-37.
4. Patil P, Bhake A, Hiwale K. Analysis of discard of whole blood and its components with suggested possible strategies to reduce it. Int J Res Med Sci. 2016;4:477-481.
5. Küçüktaş P, Şahin İ, Çalışkan E, et al. Evaluation Of Use Of Blood And Blood Components By Clinics At Health Practice And Research Center Of Duzce University. KOU Sag Bil Derg. 2019;5:25-28.
6. Chatterjee S, Wetterslev J, Sharma A, et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med. 2013;173:132-139.
7. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396-1407.
8. Garratty G, Glynn SA, McEntire R, et al. ABO and Rh(D) phenotype frequencies of differentracial/ethnic groups in the United States. Transfusion. 2004;44:703-706.
9. Yakıncı C, Durmaz Y, Şahin S, et al. ABO and Rh blood groups in Malatya. J Turgut Ozal Med Cent. 1995;2:277-279.
10. Okutur S, Alkım C, Bes C, et al. Acute upper gastrointestinal bleeding: Analysis of 230 cases. Akademik Gastroenteroloji Dergisi. 2007;6:30-36. 11. Eren C. Analysis of Distribution of ABO and Rh Blood Groups in İstanbul Province. Dicle Med J. 2019;46:241-246.
12. Efe S, Demir C, Dilek İ. Distribution of Blood and Blood Components, Indications and Early Complications of Transfusion. Eur J Gen Med. 2010;7:143-149.
13. Höbel A. Acil serviste kan ve kan ürünü transfüzyonu yapılan hastaların özellikleri ve maliyetini etkileyen faktörlerin değerlendirilmesi [Uzmanlık Tezi]. Denizli: Pamukkale Üniversitesi; 2015.
14. Kanani AN, Vachhani JH, Dholakiya SK, Upadhyay SB. Analysis on discard of blood and its products with suggested possible strategies to reduce its occurrence in a blood bank of tertiary care hospital in Western India. Glob J Transfus Med. 2017;2:130-136.
15. Chavan SK. Determination of rate and analysis of reasons for discarding blood and blood components in a blood bank of tertiary care hospital: a retrospective study. Int J Res Med Sci. 2017;5:1111-1115.
16. Novis DA, Renner S, Friedberg R, Walsh MK, Saladino AJ. Quality indicators of blood utilization: Three college of American pathologists Q-probes studies of 12,288,404 red blood cell units in 1639 hospitals. Arch Pathol Lab Med. 2002;126:150-156.
17. Veihola M. Technical Efficiency of Blood Component Preparation in Blood Centres of 10 European Countries, Academic Dissertation, Department of Public Health, Faculty of Medicine University of Helsinki, Finland, 2008.
18. Covo MZ, Cruz EDA, Maurício AB, et al. Financial cost of whole blood and blood component disposals in a Brazilian coordinating blood center. Rev Gaúcha Enferm. 2019;40:e20190033.
19. Oge T, Kilic CH, Kilic GS. Economic impact of blood transfusions: balancing cost and benefits. Eurasian J Med. 2014;46:47-49.
20. Smita M, Binay B, Gopal K, et al. Discard of blood and blood components with study of causes - A good manufacture practice. World J Pharm Med Res. 2017;3:172-175.